C-Rad AB (publ) (FRA:24C)

Market Cap	88.86M -9.3%
Revenue (ttm)	40.83M -5.8%
Net Income	970.23K -81.4%
EPS	0.03 -81.4%
Shares Out	n/a
PE Ratio	91.59
Forward PE	13.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,627
Average Volume	81
Open	2.465
Previous Close	2.505
Day's Range	2.465 - 2.465
52-Week Range	2.285 - 3.310
Beta	n/a
RSI	27.53
Earnings Date	Feb 12, 2026

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports pr...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2004
• Employees: 110
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 24C

Financial Performance

In 2025, C-Rad AB's revenue was 441.90 million, a decrease of -5.78% compared to the previous year's 469.00 million. Earnings were 10.50 million, a decrease of -81.40%.

Financial numbers in SEK